JP Morgan Chase
CPXX

JP Morgan Chase’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

JP Morgan Chase’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-542,706
Closed -$16.4M – 5087
2016
Q2 		$16.4M Buy
+542,706
New +$11M ﹤0.01% 1520

JP Morgan Chase's CPXX Position: Q3 2016 in Review

JP Morgan Chase sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 542,706 shares — an estimated $16.4M sold.

JP Morgan Chase first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $16.4M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • JP Morgan Chase reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • JP Morgan Chase sold 542,706 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $16.4M.
  • JP Morgan Chase first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • JP Morgan Chase's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $16.4M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on JP Morgan Chase's 13F filing for Q3 2016, filed 4 Nov 2016.